News about Hookipa Pharma Inc

HOOKIPA Pharma Inc. (HOOKIPA) Statement regarding potential combination for Poolbeg Pharma plc (Poolbeg)
Feb 20 2025
New York and Vienna, Austria: Insights into Hookipa Pharma s Strategic Movements and Market RegulationsFOR IMMEDIATE RELEASE NOT FOR RELEASE, PUBLIC...

Understanding Hookipa Pharma: Implications of Recent UK Disclosure Requirements and Market Regulations
Jan 10 2025
Understanding Hookipa Pharma: Implications of Recent U.K. Disclosure Requirements and Market RegulationsAs the pharmaceutical landscape continues to ...

Hookipa Pharma Reports Strategic Developments Amid UK Disclosure Compliance and Promising Market Outlook
Jan 08 2025
Breaking News: Hookipa Pharma Navigates UK Disclosure Regulations as Market Anticipates GrowthNew York and Vienna, Austria, Jan. 8, 2025 ? Hookipa Pha...

HOOKIPA Pharma Announce Key U.K. Disclosure Requirements: Implications for Shareholders and Market Performance
Jan 07 2025
In a recent press release dated January 7, 2025, HOOKIPA Pharma Inc. (NASDAQ: HOOK) informed shareholders about important updates regarding U.K. discl...

Potential Merger: Poolbeg and HOOKIPA Pharma Explore Strategic Combination Amid Struggling Share Prices
Jan 07 2025
The Landscape of Pharmaceutical Innovation: An Important Update on Poolbeg Pharma plc and HOOKIPA Pharma Inc.In the fast-paced world of biopharmaceuti...

HOOKIPA Pharma Inc. and Poolbeg Pharma Set to Revolutionize Biotech: A Strategic Collaboration Announcement,
Jan 06 2025
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE ...

Innovative Pathways: HOOKIPA Pharma Inc. and Poolbeg Pharma Set for a Game-Changing Collaboration in Biotech,
Jan 02 2025
HOOKIPA Pharma Poised to Make Waves with Preclinical Data Presentation at RAS Industry SummitNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR...

HOOKIPA Pharma to Showcase Promising Preclinical HB-700 Data at Upcoming RAS Industry Summit
Sep 24 2024
Abstract HOOKIPA Pharma Inc. (NASDAQ: HOOK) is scheduled to unveil a comprehensive preclinical proof-of-concept package for its investigational drug...

HOOKIPA Pharma*s Reverse Stock Split Signals Commitment to Boost Share Value
Jul 08 2024
Hookipa Pharma Implements Reverse Stock Split to Improve Share ValueOn July 9, 2024, HOOKIPA Pharma Inc. (NASDAQ: HOOK, HOOKIPA) will undergo a 1...

HOOKIPA Pharma Initiates Exciting Phase 1b Clinical Trial of Promising HIV Vaccine, Triggering $5 Million Milestone P...
Jul 01 2024
Combining the articles:HOOKIPA Pharma Inc. made an electrifying announcement today, revealing that the first person has been dosed in a Phase 1b clini...

Hookipa Pharma Inc. Sees Impressive 1052.361% Revenue Growth in Q1 2024 Earnings Report
May 10 2024
Hookipa Pharma Inc, a biopharmaceutical company specializing in immunotherapeutics, has faced a significant decrease in its stock value over the past ...

Hookipa Pharma Inc Faces Setback as Fourth Quarter Revenue Dips Slightly
Mar 22 2024
Hookipa Pharma Inc, a biopharmaceutical company that specializes in immunotherapeutics, has seen a drop in its shares over the course of March. The sh...

Groundbreaking Insights Unveiled: Hookipa Pharma Inc Surpasses Expectations in Fiscal Year Ending September 30, 2023
Nov 12 2023
Hookipa Pharma Inc, a biotechnology company, recently released its financial results for the third quarter of 2023. The results indicate a s...

Despite a Surge in Revenue, Hookipa Pharma Inc Struggles to Achieve Profitability in Q1 2023
May 14 2023
In a recent financial report, Hookipa Pharma Inc has recorded a substantial net loss of $-67 million during the 12 months ending in the first quarter ...